Dextran/Poly(L-histidine) Graft Copolymer for pH-Responsive Drug Delivery

Authors: Dae Hwan Kang, Young-IL Jeong, Chung-Wook Chung

Abstract:

pH-sensitive drug targeting using nanoparticles for cancer chemotherapy have been spotlighted in recent decades. Graft copolymer composed of poly (L-histidine) (PHS) and dextran (DexPHS) was synthesized and pH-sensitive nanoparticles were fabricated for pH-responsive drug delivery of doxorubicin (DOX). Nanoparticles of DexPHS showed pH-sensitive changes in particle sizes and drug release behavior, i.e. particle sizes and drug release rate were increased at acidic pH, indicating that DexPHS nanoparticles have pH-sensitive drug delivery potentials. Antitumor activity of DOX-incorporated DexPHS nanoparticles were studied using CT26 colorectal carcinoma cells. Results indicated that fluorescence intensity was higher at acidic pH than basic pH. These results indicated that DexPHS nanoparticles have pH-responsive drug targeting.

Keywords: pH-sensitive polymer, nanoparticles, block copolymer, poly (L-histidine).

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1087271

References:

[1] C. He C, X. Zhuang, Z. Tang, H. Tian, X. Chen. "Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery," Adv. Healthc. Mater. vol. 1, pp. 48-78, 2012.
[2] Y.L. Colson, M.W. Grinstaff, "Biologically responsive polymeric nanoparticles for drug delivery," Adv. Mater. vol. 24, no. 28, pp. 3878-3886, 2012.
[3] R. Liu, D. Li, B. He, X. Xu, M. Sheng, Y. Lai, G. Wang, Z. Gu, "Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles," J. Control. Release, vol. 152, pp. 49-56, 2011.
[4] D. W. Pack, D. Putnam, R. Langer, "Design of imidazole-containing endosomolytic biopolymers for gene delivery," Biotechnol. Bioeng. vol. 67, pp. 217-223, 2000.
[5] D. Putnam, A.N. Zelikin, V.A. Izumrudov, R. Langer, "Polyhistidine-PEG:DNA nanocomposites for gene delivery," Biomaterials. vol. 24, pp. 4425-4433, 2003.
[6] R.P. Johnson, Y.I. Jeong, E. Choi, C.W. Chung, D.H. Kang, S.O. Oh, H. Suh, I. Kim, "Biocompatible Poly(2-hydroxyethyl methacrylate)-b-poly(L-histidine) Hybrid Materials for pH-Sensitive Intracellular Anticancer Drug Delivery," Adv. Funct. Mater. vol. 22, pp. 1058–1068, 2012.
[7] Y.I. Jeong, C.W. Chung, D.H. Kang, "Fabrication of pH-sensitive nanoparticles using dextran/poly(L-histidine) graft copolymers," Carbohydr. Polym. Preparation for submission.
[8] R.P. Johnson, C.W. Chung, Y.I. Jeong, D.H. Kang, H. Suh, I. Kim, "Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy," Int. J. Nanomedicine. vol. 7, pp. 2497-2512, 2012.
[9] I.F. Tannock, D. Rotin, "Acid pH in tumors and its potential for therapeutic exploitation," Cancer Res. vol. 49, pp. 4373-4384, 1989.
[10] Q. Liu, Q.Q. Jiang, W.J. Yi, J. Zhang, X.C. Zhang, M.B. Wu, Y.M. Zhang, W. Zhu, X.Q. Yu, "Novel imidazole-functionalized cyclen cationic lipids: synthesis and application as non-viral gene vectors," Bioorg. Med. Chem. vol. 21, no. 11, pp. 3105-3113, 2013.
[11] N. Toriyabe, Y. Hayashi, H. Harashima. "The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine," Biomaterials. vol. 34, no. 4, pp. 1337-1343, 2013.
[12] J.H. Hwang, C.W. Choi, H.W. Kim, D.H. Kim, T.W. Kwak, H.M. Lee, C.H. Kim, C.W. Chung, Y.I. Jeong, D.H. Kang, "Nanoparticles of dextran-b-poly(L-histidine) copolymer for pH-responsive drug delivery to tumor cells," Int. J. Nanomedicine, Submitted for publication.
[13] R. Liu, B. He, D. Li, Y. Lai, J. Chang, J.Z. Tang, Z. Gu Z, "Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles," Int. J. Nanomedicine, vol. 7, pp. 4433-4446, 2012.
[14] J.L. Wu, C.G. Liu, X.L. Wang, Z.H. Huang, "Preparation and characterization of nanoparticles based on histidine-hyaluronic acid conjugates as doxorubicin carriers," J. Mater. Sci. Mater. Med. vol. 23, no. 8, pp. 1921-1929, 2012.
[15] B.S. Lee, K. Park, S. Park, G.C. Kim, H.J. Kim, S. Lee, H. Kil, S.J. Oh, D. Chi, K. Kim, K. Choi, I.C. Kwon, S.Y. Kim, "Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug," J. Control. Release. vol. 147, pp. 253-260, 2010.